Ryan Barbara
SEC CIK 1827169 · EDGAR
BoughtSold
Most active insiders at INKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ryan Barbara | Dir | — | $46.6K |
| 2 | Holcomb John Bradley | Dir | — | — |
| 3 | Kadlec Robert Peter | Dir | — | — |
| 4 | Behner Peter | Dir | — | — |
| 5 | Buell Jennifer | CEO | — | — |
| 6 | Corvese Brian | Dir | — | — |
| 7 | WIINBERG ULF | Dir | — | — |
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 10:19 | 2026-09-01 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $10.95 | +1,622 | 23.6K | +7% | +$17.8K | |
| M | 2026-06-05 18:04 | 2026-06-04 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | S - Sale | $12.76 | -1,500 | 22.0K | -6% | -$19.1K |
| M | 2026-06-02 16:05 | 2026-03-02+ | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $11.59 | +3,063 | 23.5K | +15% | +$35.5K |
| 2026-05-14 16:07 | 2026-05-13 | INDV | Indivior Pharmaceuticals, Inc. | Ryan Barbara | Dir | A - Grant | $0.00 | +6,518 | 12.2K | +114% | $0 | |
| 2026-03-13 | 2026-03-13 | INDV | Indivior Pharmaceuticals, Inc. | Ryan Barbara | Dir | P - Purchase | $31.09 | +8 | 5,724 | +0.1% | +$248.72 | |
| M | 2026-03-11 | 2026-03-09+ | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | S - Sale | $14.70 | -1,500 | 21.4K | -7% | -$22.1K |
| 2026-03-11 | 2026-03-09 | INDV | Indivior Pharmaceuticals, Inc. | Ryan Barbara | Dir | P - Purchase | $32.56 | +31 | 5,716 | +0.5% | +$1,009 | |
| M | 2026-03-04 | 2026-02-27+ | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | S - Sale | $10.85 | -500 | 22.0K | -2% | -$5,427 |
| 2026-01-28 | 2026-01-26 | INDV | Indivior Pharmaceuticals, Inc. | Ryan Barbara | Dir | A - Grant | $0.00 | +3,722 | 5,685 | +190% | $0 | |
| 2026-01-07 | 2026-01-05 | INDV | Indivior Pharmaceuticals, Inc. | Ryan Barbara | Dir | P - Purchase | $35.39 | +775 | 1,963 | +65% | +$27.4K | |
| 2025-12-03 | 2025-12-01 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $11.09 | +1,601 | 22.4K | +8% | +$17.8K | |
| 2025-09-03 | 2025-09-02 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $13.86 | +1,281 | 20.8K | +7% | +$17.8K | |
| 2025-06-04 | 2025-06-02 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $7.17 | +2,476 | 19.5K | +15% | +$17.8K | |
| 2025-03-05 | 2025-03-03 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $8.79 | +2,019 | 17.0K | +13% | +$17.7K | |
| 2024-12-03 | 2024-12-01 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $0.73 | +24.2K | 150.3K | +19% | +$17.7K | |
| 2024-09-05 | 2024-09-03 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $0.82 | +21.6K | 126.1K | +21% | +$17.8K | |
| 2024-06-05 | 2024-06-03 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $0.99 | +17.8K | 104.5K | +21% | +$17.7K | |
| 2024-03-05 | 2024-03-01 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $0.95 | +18.7K | 86.6K | +28% | +$17.8K | |
| 2023-12-05 | 2023-12-01 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $1.04 | +17.1K | 67.9K | +34% | +$17.8K | |
| 2023-09-06 | 2023-09-01 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $1.46 | +12.2K | 50.9K | +31% | +$17.8K | |
| 2023-06-02 | 2023-06-01 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $1.76 | +10.1K | 38.9K | +35% | +$17.8K | |
| 2023-03-03 | 2023-03-01 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $2.09 | +8,493 | 28.8K | +42% | +$17.8K | |
| 2022-12-05 | 2022-12-01 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $2.61 | +6,801 | 20.4K | +50% | +$17.8K | |
| 2022-09-19 | 2022-09-15 | INKT | MiNK Therapeutics, Inc. | Ryan Barbara | Dir | A - Grant | $2.62 | +13.6K | 13.6K | New | +$35.5K | |
| 2022-06-03 | 2022-06-01 | IVF | INVO Fertility, Inc. | Ryan Barbara | Dir | P - Purchase | $0.95 | +10.5K | 23.0K | +84% | +$10,000 | |
| D | 2022-01-18 | 2022-01-15 | IVF | INVO Fertility, Inc. | Ryan Barbara | Dir | A - Grant | $0.00 | +8,588 | 21.1K | +69% | $0 |
Purchase Sale Sale after option exercise All abbreviations